Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
54
GRX Quote, Financials, Valuation and Earnings
Last price:
$9.41
Seasonality move
:
-2.25%
Day range:
$9.39 - $9.47
52-week range:
$9.03 - $11.24
Dividend yield:
6.58%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
12.9K
Avg. volume:
22.8K
1-year change:
-5.77%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
GRX
Gabelli Healthcare & WellnessRx Trust
|
-- | -- | -- | -- | -- |
|
BME
Blackrock Health Sciences Trust
|
-- | -- | -- | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
GRX
Gabelli Healthcare & WellnessRx Trust
|
$9.42 | -- | -- | -- | $0.17 | 6.58% | -- |
|
BME
Blackrock Health Sciences Trust
|
$35.88 | -- | -- | -- | $0.26 | 6.52% | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
$14.04 | -- | -- | -- | $0.17 | 11.17% | -- |
|
IHF
iShares US Healthcare Providers ETF
|
$43.63 | -- | -- | -- | $0.06 | 1.02% | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
$83.22 | -- | -- | -- | $0.27 | 1.16% | -- |
|
THW
Tekla World Healthcare Fund
|
$10.25 | -- | -- | -- | $0.12 | 9.11% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
GRX
Gabelli Healthcare & WellnessRx Trust
|
-- | 0.575 | -- | -- |
|
BME
Blackrock Health Sciences Trust
|
-- | 0.612 | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | 1.021 | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | 0.813 | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | 0.248 | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | 0.704 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
GRX
Gabelli Healthcare & WellnessRx Trust
|
-- | -- | -- | -- | -- | -- |
|
BME
Blackrock Health Sciences Trust
|
-- | -- | -- | -- | -- | -- |
|
BMEZ
BlackRock Health Sciences Trust II
|
-- | -- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | -- | -- | -- | -- | -- |
Gabelli Healthcare & WellnessRx Trust vs. Competitors
-
Which has Higher Returns GRX or BME?
Blackrock Health Sciences Trust has a net margin of -- compared to Gabelli Healthcare & WellnessRx Trust's net margin of --. Gabelli Healthcare & WellnessRx Trust's return on equity of -- beat Blackrock Health Sciences Trust's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GRXGabelli Healthcare & WellnessRx Trust-- -- -- BMEBlackrock Health Sciences Trust-- -- -- -
What do Analysts Say About GRX or BME?
Gabelli Healthcare & WellnessRx Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Blackrock Health Sciences Trust has an analysts' consensus of -- which suggests that it could fall by --. Given that Gabelli Healthcare & WellnessRx Trust has higher upside potential than Blackrock Health Sciences Trust, analysts believe Gabelli Healthcare & WellnessRx Trust is more attractive than Blackrock Health Sciences Trust.
Company Buy Ratings Hold Ratings Sell Ratings GRXGabelli Healthcare & WellnessRx Trust0 0 0 BMEBlackrock Health Sciences Trust0 0 0 -
Is GRX or BME More Risky?
Gabelli Healthcare & WellnessRx Trust has a beta of 0.995, which suggesting that the stock is 0.513% less volatile than S&P 500. In comparison Blackrock Health Sciences Trust has a beta of 0.676, suggesting its less volatile than the S&P 500 by 32.401%.
-
Which is a Better Dividend Stock GRX or BME?
Gabelli Healthcare & WellnessRx Trust has a quarterly dividend of $0.17 per share corresponding to a yield of 6.58%. Blackrock Health Sciences Trust offers a yield of 6.52% to investors and pays a quarterly dividend of $0.26 per share. Gabelli Healthcare & WellnessRx Trust pays -- of its earnings as a dividend. Blackrock Health Sciences Trust pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GRX or BME?
Gabelli Healthcare & WellnessRx Trust quarterly revenues are --, which are smaller than Blackrock Health Sciences Trust quarterly revenues of --. Gabelli Healthcare & WellnessRx Trust's net income of -- is lower than Blackrock Health Sciences Trust's net income of --. Notably, Gabelli Healthcare & WellnessRx Trust's price-to-earnings ratio is -- while Blackrock Health Sciences Trust's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Gabelli Healthcare & WellnessRx Trust is -- versus -- for Blackrock Health Sciences Trust. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRXGabelli Healthcare & WellnessRx Trust-- -- -- -- BMEBlackrock Health Sciences Trust-- -- -- --
-
Which has Higher Returns GRX or BMEZ?
BlackRock Health Sciences Trust II has a net margin of -- compared to Gabelli Healthcare & WellnessRx Trust's net margin of --. Gabelli Healthcare & WellnessRx Trust's return on equity of -- beat BlackRock Health Sciences Trust II's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GRXGabelli Healthcare & WellnessRx Trust-- -- -- BMEZBlackRock Health Sciences Trust II-- -- -- -
What do Analysts Say About GRX or BMEZ?
Gabelli Healthcare & WellnessRx Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand BlackRock Health Sciences Trust II has an analysts' consensus of -- which suggests that it could fall by --. Given that Gabelli Healthcare & WellnessRx Trust has higher upside potential than BlackRock Health Sciences Trust II, analysts believe Gabelli Healthcare & WellnessRx Trust is more attractive than BlackRock Health Sciences Trust II.
Company Buy Ratings Hold Ratings Sell Ratings GRXGabelli Healthcare & WellnessRx Trust0 0 0 BMEZBlackRock Health Sciences Trust II0 0 0 -
Is GRX or BMEZ More Risky?
Gabelli Healthcare & WellnessRx Trust has a beta of 0.995, which suggesting that the stock is 0.513% less volatile than S&P 500. In comparison BlackRock Health Sciences Trust II has a beta of 1.069, suggesting its more volatile than the S&P 500 by 6.85%.
-
Which is a Better Dividend Stock GRX or BMEZ?
Gabelli Healthcare & WellnessRx Trust has a quarterly dividend of $0.17 per share corresponding to a yield of 6.58%. BlackRock Health Sciences Trust II offers a yield of 11.17% to investors and pays a quarterly dividend of $0.17 per share. Gabelli Healthcare & WellnessRx Trust pays -- of its earnings as a dividend. BlackRock Health Sciences Trust II pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GRX or BMEZ?
Gabelli Healthcare & WellnessRx Trust quarterly revenues are --, which are smaller than BlackRock Health Sciences Trust II quarterly revenues of --. Gabelli Healthcare & WellnessRx Trust's net income of -- is lower than BlackRock Health Sciences Trust II's net income of --. Notably, Gabelli Healthcare & WellnessRx Trust's price-to-earnings ratio is -- while BlackRock Health Sciences Trust II's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Gabelli Healthcare & WellnessRx Trust is -- versus -- for BlackRock Health Sciences Trust II. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRXGabelli Healthcare & WellnessRx Trust-- -- -- -- BMEZBlackRock Health Sciences Trust II-- -- -- --
-
Which has Higher Returns GRX or IHF?
iShares US Healthcare Providers ETF has a net margin of -- compared to Gabelli Healthcare & WellnessRx Trust's net margin of --. Gabelli Healthcare & WellnessRx Trust's return on equity of -- beat iShares US Healthcare Providers ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GRXGabelli Healthcare & WellnessRx Trust-- -- -- IHFiShares US Healthcare Providers ETF-- -- -- -
What do Analysts Say About GRX or IHF?
Gabelli Healthcare & WellnessRx Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare Providers ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Gabelli Healthcare & WellnessRx Trust has higher upside potential than iShares US Healthcare Providers ETF, analysts believe Gabelli Healthcare & WellnessRx Trust is more attractive than iShares US Healthcare Providers ETF.
Company Buy Ratings Hold Ratings Sell Ratings GRXGabelli Healthcare & WellnessRx Trust0 0 0 IHFiShares US Healthcare Providers ETF0 0 0 -
Is GRX or IHF More Risky?
Gabelli Healthcare & WellnessRx Trust has a beta of 0.995, which suggesting that the stock is 0.513% less volatile than S&P 500. In comparison iShares US Healthcare Providers ETF has a beta of 0.729, suggesting its less volatile than the S&P 500 by 27.109%.
-
Which is a Better Dividend Stock GRX or IHF?
Gabelli Healthcare & WellnessRx Trust has a quarterly dividend of $0.17 per share corresponding to a yield of 6.58%. iShares US Healthcare Providers ETF offers a yield of 1.02% to investors and pays a quarterly dividend of $0.06 per share. Gabelli Healthcare & WellnessRx Trust pays -- of its earnings as a dividend. iShares US Healthcare Providers ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GRX or IHF?
Gabelli Healthcare & WellnessRx Trust quarterly revenues are --, which are smaller than iShares US Healthcare Providers ETF quarterly revenues of --. Gabelli Healthcare & WellnessRx Trust's net income of -- is lower than iShares US Healthcare Providers ETF's net income of --. Notably, Gabelli Healthcare & WellnessRx Trust's price-to-earnings ratio is -- while iShares US Healthcare Providers ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Gabelli Healthcare & WellnessRx Trust is -- versus -- for iShares US Healthcare Providers ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRXGabelli Healthcare & WellnessRx Trust-- -- -- -- IHFiShares US Healthcare Providers ETF-- -- -- --
-
Which has Higher Returns GRX or PJP?
Invesco Pharmaceuticals ETF has a net margin of -- compared to Gabelli Healthcare & WellnessRx Trust's net margin of --. Gabelli Healthcare & WellnessRx Trust's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GRXGabelli Healthcare & WellnessRx Trust-- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- -
What do Analysts Say About GRX or PJP?
Gabelli Healthcare & WellnessRx Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Gabelli Healthcare & WellnessRx Trust has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe Gabelli Healthcare & WellnessRx Trust is more attractive than Invesco Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings GRXGabelli Healthcare & WellnessRx Trust0 0 0 PJPInvesco Pharmaceuticals ETF0 0 0 -
Is GRX or PJP More Risky?
Gabelli Healthcare & WellnessRx Trust has a beta of 0.995, which suggesting that the stock is 0.513% less volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.502, suggesting its less volatile than the S&P 500 by 49.771%.
-
Which is a Better Dividend Stock GRX or PJP?
Gabelli Healthcare & WellnessRx Trust has a quarterly dividend of $0.17 per share corresponding to a yield of 6.58%. Invesco Pharmaceuticals ETF offers a yield of 1.16% to investors and pays a quarterly dividend of $0.27 per share. Gabelli Healthcare & WellnessRx Trust pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GRX or PJP?
Gabelli Healthcare & WellnessRx Trust quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. Gabelli Healthcare & WellnessRx Trust's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, Gabelli Healthcare & WellnessRx Trust's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Gabelli Healthcare & WellnessRx Trust is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRXGabelli Healthcare & WellnessRx Trust-- -- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns GRX or THW?
Tekla World Healthcare Fund has a net margin of -- compared to Gabelli Healthcare & WellnessRx Trust's net margin of --. Gabelli Healthcare & WellnessRx Trust's return on equity of -- beat Tekla World Healthcare Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GRXGabelli Healthcare & WellnessRx Trust-- -- -- THWTekla World Healthcare Fund-- -- -- -
What do Analysts Say About GRX or THW?
Gabelli Healthcare & WellnessRx Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Tekla World Healthcare Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Gabelli Healthcare & WellnessRx Trust has higher upside potential than Tekla World Healthcare Fund, analysts believe Gabelli Healthcare & WellnessRx Trust is more attractive than Tekla World Healthcare Fund.
Company Buy Ratings Hold Ratings Sell Ratings GRXGabelli Healthcare & WellnessRx Trust0 0 0 THWTekla World Healthcare Fund0 0 0 -
Is GRX or THW More Risky?
Gabelli Healthcare & WellnessRx Trust has a beta of 0.995, which suggesting that the stock is 0.513% less volatile than S&P 500. In comparison Tekla World Healthcare Fund has a beta of 0.865, suggesting its less volatile than the S&P 500 by 13.55%.
-
Which is a Better Dividend Stock GRX or THW?
Gabelli Healthcare & WellnessRx Trust has a quarterly dividend of $0.17 per share corresponding to a yield of 6.58%. Tekla World Healthcare Fund offers a yield of 9.11% to investors and pays a quarterly dividend of $0.12 per share. Gabelli Healthcare & WellnessRx Trust pays -- of its earnings as a dividend. Tekla World Healthcare Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GRX or THW?
Gabelli Healthcare & WellnessRx Trust quarterly revenues are --, which are smaller than Tekla World Healthcare Fund quarterly revenues of --. Gabelli Healthcare & WellnessRx Trust's net income of -- is lower than Tekla World Healthcare Fund's net income of --. Notably, Gabelli Healthcare & WellnessRx Trust's price-to-earnings ratio is -- while Tekla World Healthcare Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Gabelli Healthcare & WellnessRx Trust is -- versus -- for Tekla World Healthcare Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GRXGabelli Healthcare & WellnessRx Trust-- -- -- -- THWTekla World Healthcare Fund-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
72
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
